About the Breakfast Sessions
Breakfast sessions are available for all delegates to attend (excluding exhibitors) and spaces are limited and strictly on a first come first serve basis. A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence.
Please click on the links below for more information on the breakfast topics. In order to attend the breakfast sessions, you will be required to indicate your attendance as part of your registration form.
Thursday 16 June
Breakfast Session 1 - Supported by Maurice Blackburn Lawyers- Topic TBC
Friday 17 June
Saturday 18 June
Thursday 16 June
Title: Update on Dust and Occupational Cancers and Where to From Here
Time: 0745 - 0915 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.45am - 8.15am). This will be served outside the meeting room.
Presenter: to be confirmed
Description: to be confirmed
Title: Nursing Ovarian Cancer Patients: How to help women get the most from their maintenance therapy
Time: 0745 - 0915 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.45am - 8.15am). This will be served outside the meeting room.
Presenters: Anne Mellon, Dr Niara Oliveira and Susie O'Keefe
Description: click here to download the flyer
Title: ONCADERM Education: Identify and manage cutaneous reactions in patients being treated with EGFR inhibitors.
Time: 0715 - 0915 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.15am - 7.45am). This will be served outside the meeting room.
Presenter: Professor Pablo Fernández-Peñas
Description:
The ONCADERM program aims to provide structured education to assist with the prevention, early identification and optimal management of cutaneous reactions associated with EGFR inhibitor therapy.
Learning Outcomes:
- Understand the mechanism of action of how the EGFR inhibitor affects the structure and function of the skin
- Recognise and describe the various cutaneous reactions that occur in patients being treated with EGFR inhibitors
- Follow general management pathways for treating cutaneous reactions associated with EGFR inhibitor treatment
Friday 17 June
Title: Renal Cell Carcinoma: A focus on managing your patients on IO + TKI combination therapy
Time: 0730 - 0830 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.00am - 7.30am). This will be served outside the meeting room.
Presenter: Dr Niara Oliveira, Medical Oncologist
Description:
Learning outcomes:
- Review key facts about advanced renal cell carcinoma (RCC)
- Review the efficacy and safety considerations of a first line IO+TKI combination therapy
- Discuss monitoring and management of adverse reactions associated with the IO+TKI combination therapy
Title: Metastatic Breast Cancer: Helping patients navigate the CDK4/6i discussion
Time: 0730 - 0830 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.00am - 7.30am). This will be served outside the meeting room.
Presenters: Dr Michelle Morris
Description: to be confirmed
Saturday 18 June
Title: Changing Treatment Paradigms in HER2-positive Metastatic Breast Cancer and the Role of ENHERTU (trastuzumab-deruxtecan)
Time: 0730 - 0830 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.00am - 7.30am). This will be served outside the meeting room.
Presenters: to be confirmed
Description: to be confirmed
Title: See Beyond the Negative: Advances in the Treatment of TNBC
Time: 0730 - 0830 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.00am - 7.30am). This will be served outside the meeting room.
Presenters: to be confirmed
Description: to be confirmed